CA3141407A1 - Method for treating asthma - Google Patents

Method for treating asthma Download PDF

Info

Publication number
CA3141407A1
CA3141407A1 CA3141407A CA3141407A CA3141407A1 CA 3141407 A1 CA3141407 A1 CA 3141407A1 CA 3141407 A CA3141407 A CA 3141407A CA 3141407 A CA3141407 A CA 3141407A CA 3141407 A1 CA3141407 A1 CA 3141407A1
Authority
CA
Canada
Prior art keywords
dapansutrile
asthma
airway
mice
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3141407A
Other languages
English (en)
French (fr)
Inventor
Charles A. Dinarello
Carlo MARCHETTI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Olatec Therapeutics Inc
Original Assignee
Olatec Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Olatec Therapeutics Inc filed Critical Olatec Therapeutics Inc
Publication of CA3141407A1 publication Critical patent/CA3141407A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA3141407A 2019-06-17 2020-06-15 Method for treating asthma Pending CA3141407A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962862434P 2019-06-17 2019-06-17
US62/862,434 2019-06-17
PCT/US2020/037696 WO2020257093A1 (en) 2019-06-17 2020-06-15 Method for treating asthma

Publications (1)

Publication Number Publication Date
CA3141407A1 true CA3141407A1 (en) 2020-12-24

Family

ID=74040873

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3141407A Pending CA3141407A1 (en) 2019-06-17 2020-06-15 Method for treating asthma

Country Status (8)

Country Link
US (1) US20220087969A1 (cg-RX-API-DMAC7.html)
EP (1) EP3983070B1 (cg-RX-API-DMAC7.html)
JP (1) JP7607939B2 (cg-RX-API-DMAC7.html)
CN (1) CN114007690B (cg-RX-API-DMAC7.html)
AU (1) AU2020296829B2 (cg-RX-API-DMAC7.html)
CA (1) CA3141407A1 (cg-RX-API-DMAC7.html)
MX (1) MX2021015561A (cg-RX-API-DMAC7.html)
WO (1) WO2020257093A1 (cg-RX-API-DMAC7.html)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2013006708A (es) * 2010-12-15 2013-09-13 Olatec Ind Llc Composicion de 3-metanosulfonilpropionitrilo para el tratamiento de la inflamacion y el dolor.
FR3046933B1 (fr) * 2016-01-25 2018-03-02 Galderma Research & Development Inhibiteurs nlrp3 pour le traitement des pathologies cutanees inflammatoires
MA44729A (fr) * 2016-04-18 2021-05-12 Novartis Ag Composés et compositions pour traiter des états associés à une activité de nlrp

Also Published As

Publication number Publication date
CN114007690B (zh) 2024-03-01
US20220087969A1 (en) 2022-03-24
EP3983070B1 (en) 2024-09-11
EP3983070A1 (en) 2022-04-20
AU2020296829A1 (en) 2022-02-10
WO2020257093A1 (en) 2020-12-24
JP7607939B2 (ja) 2025-01-06
MX2021015561A (es) 2022-01-24
JP2022536932A (ja) 2022-08-22
EP3983070A4 (en) 2023-04-26
CN114007690A (zh) 2022-02-01
AU2020296829B2 (en) 2026-01-15

Similar Documents

Publication Publication Date Title
PT100144B (pt) Composicoes farmaceuticas contendo rapamicina e metodo para o tratamento de inflamacoes pulmonares utilizando-as
CN116327743A (zh) 黄芩素吸入制剂在制备急性肺损伤治疗药物中的应用
Yu et al. Pulmonary delivery of icariin-phospholipid complex prolongs lung retention and improves therapeutic efficacy in mice with acute lung injury/ARDS
WO2021113334A1 (en) Treatment of lower airways disorders
AU2020296829B2 (en) Method for treating asthma
JP7309791B2 (ja) イソグリチルリチン酸またはその塩の吸入製剤および呼吸器疾患を治療する薬物の製造におけるそれらの使用
US20240252581A1 (en) Compositions and methods for treating respiratory distress
US20120060834A1 (en) Pharmaceutical preparation to be administered into respiratory organs for treating or preventing inflammatory respiratory diseases, and method for treating or preventing such diseases
KR20130055580A (ko) 기도의 염증 및 이상성 점액섬모 전달의 치료법으로서의 에어로졸화 댑손
CN100394981C (zh) 一种人粒细胞巨噬细胞集落刺激因子喷雾剂及其制备方法
JP2021176903A5 (cg-RX-API-DMAC7.html)
KR102872873B1 (ko) 바이러스 감염증 치료용 약학 조성물 및 치료 방법
CN101203229A (zh) 用于治疗或预防由肺泡破坏引起的肺病的克拉霉素或其盐
WO2021244515A1 (zh) 改善呼吸系统损伤的医药组合物与用于制备改善呼吸系统损伤的医药组合物的用途
CN112656794B (zh) 吡咯喹啉醌或其盐在制备用于防治前列腺增生药物中的用途及药物组合物
US8722098B2 (en) Ecklonia cava extracts for alleviating or preventing asthmatic reactions
CN108530348A (zh) 一种治疗慢性阻塞性肺疾病的药物及其制备方法
CN118892484A (zh) 4-氨基-1-苄基哌啶在制备预防和/或治疗急性肺损伤药物中的应用
Shaikh et al. A Review on Novel Approaches to the Treatment of Asthma
CN120000665A (zh) 雷公藤红素在制备防治ilc2细胞介导的过敏性肺部炎症药物中的应用
US20090022915A1 (en) Particle and preparation containing the particle
JP2022014868A (ja) 慢性閉塞性肺疾患の急性増悪の治療薬の調製におけるTanreqingの応用
HK40030149A (en) Using of tanreqing in the preparation of drugs for the treatment of acute exacerbation of chronic obstructive pulmonary disease
EP4051300A1 (en) Composition for the prevention and treatment of diseases of the respiratory system

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20240529

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - SMALL

Year of fee payment: 5

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250603

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250603

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20250616

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20251001

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20251204

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20251204

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20251204

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20260224

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - SMALL

Year of fee payment: 6

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260602

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260602

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20260623

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20260715

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20260715

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20260715